000 01429 a2200361 4500
005 20250512021113.0
264 0 _c19891219
008 198912s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/24.suppl_a.85
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aInderlied, C B
245 0 0 _aBacteriostatic and bactericidal in-vitro activity of meropenem against clinical isolates, including Mycobacterium avium complex.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cSep 1989
300 _a85-99 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmikacin
_xpharmacology
650 0 4 _aBacteria
_xdrug effects
650 0 4 _aBacterial Infections
_xmicrobiology
650 0 4 _aCarbapenems
_xpharmacology
650 0 4 _aDrug Synergism
650 0 4 _aGram-Negative Bacteria
_xdrug effects
650 0 4 _aGram-Positive Bacteria
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMeropenem
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMycobacterium avium Complex
_xdrug effects
650 0 4 _aThienamycins
_xpharmacology
700 1 _aLancero, M G
700 1 _aYoung, L S
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 24 Suppl A
_gp. 85-99
856 4 0 _uhttps://doi.org/10.1093/jac/24.suppl_a.85
_zAvailable from publisher's website
999 _c2814082
_d2814082